摘要
Duchenne型肌营养不良症是一种变异表达的疾病,是由于基因突变而引起的。其特点是进行性肌肉无力和扩张型心肌病。帧内营养不良蛋白突变引起一种临床中度疾病,名为Becker肌营养不良症。我们的目的是研究遗传性心肌病和贝克肌营养不良症家族的临床和遗传特征。5岁时诊断为精神运动性迟滞。12岁时出现不对称左室肥厚和长QT间期。随后出现轻度肌肉无力。在该指数病例中发现了3个遗传变异:MYBPC 3基因的P.Arg891Alafs*160,KCNJ 5基因的p.Thr263Met和DMD基因中的p.Ser2437_Ile2554delinsPhe。后者将产生dystrophin基因第51和52号外显子的帧内缺失。一项家庭研究显示,父亲和3位叔叔是MYBPC 3突变的携带者。母亲和外祖父是另外两个变体的携带者。这位80岁的祖父患有肌营养不良蛋白突变,没有心肌病或肌肉无力的迹象。DMD基因外显子51和52的缺失已被认为是Duchenne的治疗策略之一,这与正常的预期寿命和无肌疾病症状的半男性是一致的。
关键词: Duchenne肌营养不良,心肌病,肌营养不良,外显子,缺失,MYBPC 3,肌无力症状。
Current Gene Therapy
Title:Phenotypic Characterization of a Family With An In-frame Deletion in the DMD Gene and Variable Penetrance
Volume: 18 Issue: 4
关键词: Duchenne肌营养不良,心肌病,肌营养不良,外显子,缺失,MYBPC 3,肌无力症状。
摘要: Duchenne muscular dystrophy is a disorder with variable expression caused by framedisrupting mutations in the dystrophin gene. It is characterized by progressive muscle weakness and dilated cardiomyopathy. In-frame dystrophin mutations cause a clinically moderate disorder named Becker muscular dystrophy. Our aim was to study the clinical and genetic characteristics of a family with inherited cardiomyopathy and Becker muscular dystrophy.
The index case was diagnosed with psychomotor retardation at 5 years of age. Asymmetric left ventricular hypertrophy and a long QT interval were evidenced at the age of 12. Mild muscular weakness was developed subsequently. Three genetic variants were identified in the index case: p.Arg891Alafs*160 in the MYBPC3 gene, p.Thr263Met in the KCNJ5 gene, and p.Ser2437_Ile2554delinsPhe in the DMD gene. The latter was expected to generate an in-frame deletion of exons 51 and 52 of the dystrophin gene.
A family study revealed that the father and 3 uncles were carriers of the MYBPC3 mutation. The mother and a maternal grandfather were carriers of the other 2 variants. The 80-year-old grandfather, who had the dystrophin mutation, showed no sign of cardiomyopathy or muscular weakness.
The deletion of exons 51 and 52 in the DMD gene, which has been proposed as one of the therapeutic strategies for Duchenne, is consistent with a normal life expectancy and the absence of myopathic symptoms in hemizygous males.
Export Options
About this article
Cite this article as:
Phenotypic Characterization of a Family With An In-frame Deletion in the DMD Gene and Variable Penetrance, Current Gene Therapy 2018; 18 (4) . https://dx.doi.org/10.2174/1566523218666180709125346
DOI https://dx.doi.org/10.2174/1566523218666180709125346 |
Print ISSN 1566-5232 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5631 |
Call for Papers in Thematic Issues
Programmed Cell Death Genes in Oncology: Pioneering Therapeutic and Diagnostic Frontiers (BMS-CGT-2024-HT-45)
Programmed Cell Death (PCD) is recognized as a pivotal biological mechanism with far-reaching effects in the realm of cancer therapy. This complex process encompasses a variety of cell death modalities, including apoptosis, autophagic cell death, pyroptosis, and ferroptosis, each of which contributes to the intricate landscape of cancer development and ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Bidirectional Nature of Cardiovascular and Kidney Disease
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) A Review on the Sex Differences in Organ and System Pathology with Alcohol Drinking
Current Drug Abuse Reviews CYP-Mediated Clozapine Interactions: How Predictable Are They?
Current Drug Metabolism Voltammetric Stripping Methods for Direct Determination of Disopyramide
Current Pharmaceutical Analysis Coated with Nanomaterials Intraocular Lenses, Ophthalmic and Human Body Implantable Devices with High Catalytic Antioxidant Activities: A New Nanotechnology Strategy of Peroxidase Cellular Enzyme Mimics Increasing the Biocompatibility and Therapeutic Deployment of the Medical Prosthetic Device
Recent Patents on Drug Delivery & Formulation Effectors of Fatty Acid Oxidation Reduction: Promising New Anti-Ischaemic Agents
Current Pharmaceutical Design Physicians’ Perception About Use of Vitamin B12 in the Treatment or Prevention of Diabetic Neuropathy: A Cross-sectional Survey in Saudi Arabia
Current Diabetes Reviews Imaging of Organ Metabolism in Obesity and Diabetes: Treatment Perspectives
Current Pharmaceutical Design Highly Active Antiretroviral Therapy and Cardiovascular Complications in HIV-Infected Patients
Current Pharmaceutical Design Susceptibility Genes in Hypertension
Current Pharmaceutical Design Pulmonary Arterial Hypertension in HIV-infected Patients
Current Hypertension Reviews Current Status of Anti-Picornavirus Therapies
Current Pharmaceutical Design Subject Index to Volume 4
Current Gene Therapy Secretory Leukocyte Protease Inhibitor: More than Just A Protease Inhibitor
Current Immunology Reviews (Discontinued) Unfolding Cardiac Amyloidosis –From Pathophysiology to Cure
Current Medicinal Chemistry A Mini-Review on Cardiovascular and Hematological Complications of COVID-19
Coronaviruses Modulation of the Rho/ROCK Pathway in Heart and Lung after Thorax Irradiation Reveals Targets to Improve Normal Tissue Toxicity
Current Drug Targets Autophagy and Mitochondria in Obesity and Type 2 Diabetes
Current Diabetes Reviews Poly(ADP-Ribose) Polymerase Inhibitors: New Pharmacological Functions and Potential Clinical Implications
Current Pharmaceutical Design Cardioprotective Effects of the I<sub>f</sub> Current Inhibition by Ivabradine During Cardiac Dysfunction
Current Pharmaceutical Biotechnology